Basics AbCellera Biologics Inc. IPO Date: December 11, 2020 Sector: Healthcare Industry: Biotech Market Cap: $591M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 3.01% Avg Daily Range (30 D): $0.06 | 2.63% Avg Daily Range (90 D): $0.08 | 3.20% Institutional Daily Volume Avg Daily Volume: 1.98M Avg Daily Volume (30 D): 3.81M Avg Daily Volume (90 D): 4.08M Trade Size Avg Trade Size (Sh.): 148 Avg Trade Size (Sh.) (30 D): 391 Avg Trade Size (Sh.) (90 D): 345 Institutional Trades Total Inst.Trades: 1,152 Avg Inst. Trade: $1.9M Avg Inst. Trade (30 D): $1.74M Avg Inst. Trade (90 D): $1.65M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.12M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $.55M Avg Closing Volume: 202.93K         News Jun 13, 2024 @ 9:40 AM Down 57%, Is AbCellera Biologics a Buy on the Dip?... Source: newsfeedback@fool.com (Cory Renauer) May 8, 2024 @ 8:30 AM AbCellera Biologics (ABCL) Q1 2024 Earnings Call T... Source: newsfeedback@fool.com (Motley Fool Transcribing) May 7, 2024 @ 10:05 PM AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, M... Source: Zacks Equity Research May 1, 2024 @ 2:01 PM Cytokinetics (CYTK) May Report Negative Earnings: ... Source: Zacks Equity Research Apr 30, 2024 @ 2:01 PM Analysts Estimate AbCellera Biologics Inc. (ABCL) ... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.15 $-.17 Diluted EPS $-.15 $-.17 Revenue $ $ 4.24M $ 6.51M Gross Profit $ $ $ Net Income / Loss $ $ -45.62M $ -51.11M Operating Income / Loss $ $ -62.66M $ -93.66M Cost of Revenue $ $ $ Net Cash Flow $ $ 2.94M $ -21.67M PE Ratio